The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2022
Filed:
Apr. 11, 2017
Applicant:
Obsidian Therapeutics, Inc., Cambridge, MA (US);
Inventors:
Peter Barrett, Cambridge, MA (US);
Michael N. Gladstone, Cambridge, MA (US);
Tariq A. Kassum, Cambridge, MA (US);
Vipin Suri, Belmont, MA (US);
Dan Jun Li, Cambridge, MA (US);
Dexue Sun, Cambridge, MA (US);
Brian Dolinski, Cambridge, MA (US);
Assignee:
OBSIDIAN THERAPEUTICS, INC., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/52 (2006.01); C12N 9/90 (2006.01); A61K 48/00 (2006.01); C07K 16/28 (2006.01); C07K 14/00 (2006.01); A61P 3/08 (2006.01); A61K 35/17 (2015.01); C07K 14/195 (2006.01); C07K 14/54 (2006.01); C07K 14/605 (2006.01); C07K 14/725 (2006.01); C07K 14/705 (2006.01); C12N 5/0789 (2010.01); C12N 9/22 (2006.01); C12N 9/00 (2006.01); C12N 15/11 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 35/17 (2013.01); A61P 3/08 (2018.01); C07K 14/00 (2013.01); C07K 14/195 (2013.01); C07K 14/5428 (2013.01); C07K 14/5443 (2013.01); C07K 14/605 (2013.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 14/70578 (2013.01); C07K 16/2803 (2013.01); C12N 5/0647 (2013.01); C12N 9/22 (2013.01); C12N 9/93 (2013.01); C12N 15/11 (2013.01); C12Y 603/04016 (2013.01); A61K 38/00 (2013.01); C07K 2317/622 (2013.01); C07K 2319/00 (2013.01); C07K 2319/03 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01); C07K 2319/50 (2013.01); C12N 2310/20 (2017.05); C12N 2501/125 (2013.01); C12N 2501/145 (2013.01); C12N 2501/22 (2013.01); C12N 2501/2303 (2013.01); C12N 2501/2316 (2013.01); C12N 2800/80 (2013.01);
Abstract
The present invention provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.